Members: $225Nonmembers: $330
Not all HRPP programs have equal resources or the same compliance needs, yet every HRPP—regardless of size—must have compliance and monitoring processes in place to hep ensure adherence to the Common Rule (45 CFR 46), FDA human subjects regulations (21 CFR Parts 50 and 56), and the ethical principles that guide research oversight. Programs must structure their processes o they fulfill required regulatory functions such as review, continuing oversight, reporting, and documentation, while maintaining flexibility to adapt to institutional constraints and changing operational environments.
In this session, speakers will discuss how their QA/QI program structures and models. They will highlight how to partner with the IRB and approaches to meeting mandated compliance activities while managing program size, staff capacity, and institutional priorities.